Cargando…
Prevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structure
OBJECTIVE: Hyperoxia exposure leads to the development of lung injury and bronchial hyperreactivity (BHR) via involvement of nitric oxide (NO) pathway. We aimed at characterizing whether the stimulation of the NO pathway by sildenafil or vasoactive intestinal peptide (VIP) is able to prevent the hyp...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261898/ https://www.ncbi.nlm.nih.gov/pubmed/25117627 http://dx.doi.org/10.1186/1465-9921-15-81 |
_version_ | 1782348350171906048 |
---|---|
author | Czövek, Dorottya Peták, Ferenc Donati, Yves Belin, Xavier Pache, Jean-Claude Barazzone Argiroffo, Constance Habre, Walid |
author_facet | Czövek, Dorottya Peták, Ferenc Donati, Yves Belin, Xavier Pache, Jean-Claude Barazzone Argiroffo, Constance Habre, Walid |
author_sort | Czövek, Dorottya |
collection | PubMed |
description | OBJECTIVE: Hyperoxia exposure leads to the development of lung injury and bronchial hyperreactivity (BHR) via involvement of nitric oxide (NO) pathway. We aimed at characterizing whether the stimulation of the NO pathway by sildenafil or vasoactive intestinal peptide (VIP) is able to prevent the hyperoxia-induced development of BHR. The respective roles of the preserved lung volume and alveolar architecture, the anti-inflammatory and anti-apoptotic potentials of these treatments in the diminished lung responsiveness were also characterized. MATERIALS AND METHODS: Immature (28-day-old) rats were exposed for 72 hours to room air (Group C), hyperoxia (>95%, Group HC), or hyperoxia with the concomitant administration of vasoactive intestinal peptide (VIP, Group HV) or sildenafil (Group HS). Following exposure, the end-expiratory lung volume (EELV) was assessed plethysmographically. Airway and respiratory tissue mechanics were measured under baseline conditions and following incremental doses of methacholine to assess BHR. Inflammation was assessed by analyzing the bronchoalveolar lavage fluid (BALF), while biochemical and histological analyses were used to characterize the apoptotic and structural changes in the lungs. RESULTS: The BHR, the increased EELV, the aberrant alveolarization, and the infiltration of inflammatory cells into the BALF that developed in Group HC were all suppressed significantly by VIP or sildenafil treatment. The number of apoptotic cells increased significantly in Group HC, with no evidence of statistically significant effects on this adverse change in Groups HS and HV. CONCLUSIONS: These findings suggest that stimulating the NO pathway by sildenafil and VIP exert their beneficial effect against hyperoxia-induced BHR via preserving normal EELV, inhibiting airway inflammation and preserving the physiological lung structure, whereas the antiapoptotic potential of these treatments were not apparent in this process. |
format | Online Article Text |
id | pubmed-4261898 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42618982014-12-10 Prevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structure Czövek, Dorottya Peták, Ferenc Donati, Yves Belin, Xavier Pache, Jean-Claude Barazzone Argiroffo, Constance Habre, Walid Respir Res Research OBJECTIVE: Hyperoxia exposure leads to the development of lung injury and bronchial hyperreactivity (BHR) via involvement of nitric oxide (NO) pathway. We aimed at characterizing whether the stimulation of the NO pathway by sildenafil or vasoactive intestinal peptide (VIP) is able to prevent the hyperoxia-induced development of BHR. The respective roles of the preserved lung volume and alveolar architecture, the anti-inflammatory and anti-apoptotic potentials of these treatments in the diminished lung responsiveness were also characterized. MATERIALS AND METHODS: Immature (28-day-old) rats were exposed for 72 hours to room air (Group C), hyperoxia (>95%, Group HC), or hyperoxia with the concomitant administration of vasoactive intestinal peptide (VIP, Group HV) or sildenafil (Group HS). Following exposure, the end-expiratory lung volume (EELV) was assessed plethysmographically. Airway and respiratory tissue mechanics were measured under baseline conditions and following incremental doses of methacholine to assess BHR. Inflammation was assessed by analyzing the bronchoalveolar lavage fluid (BALF), while biochemical and histological analyses were used to characterize the apoptotic and structural changes in the lungs. RESULTS: The BHR, the increased EELV, the aberrant alveolarization, and the infiltration of inflammatory cells into the BALF that developed in Group HC were all suppressed significantly by VIP or sildenafil treatment. The number of apoptotic cells increased significantly in Group HC, with no evidence of statistically significant effects on this adverse change in Groups HS and HV. CONCLUSIONS: These findings suggest that stimulating the NO pathway by sildenafil and VIP exert their beneficial effect against hyperoxia-induced BHR via preserving normal EELV, inhibiting airway inflammation and preserving the physiological lung structure, whereas the antiapoptotic potential of these treatments were not apparent in this process. BioMed Central 2014-08-13 2014 /pmc/articles/PMC4261898/ /pubmed/25117627 http://dx.doi.org/10.1186/1465-9921-15-81 Text en © Czövek et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Czövek, Dorottya Peták, Ferenc Donati, Yves Belin, Xavier Pache, Jean-Claude Barazzone Argiroffo, Constance Habre, Walid Prevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structure |
title | Prevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structure |
title_full | Prevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structure |
title_fullStr | Prevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structure |
title_full_unstemmed | Prevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structure |
title_short | Prevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structure |
title_sort | prevention of hyperoxia-induced bronchial hyperreactivity by sildenafil and vasoactive intestinal peptide: impact of preserved lung function and structure |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261898/ https://www.ncbi.nlm.nih.gov/pubmed/25117627 http://dx.doi.org/10.1186/1465-9921-15-81 |
work_keys_str_mv | AT czovekdorottya preventionofhyperoxiainducedbronchialhyperreactivitybysildenafilandvasoactiveintestinalpeptideimpactofpreservedlungfunctionandstructure AT petakferenc preventionofhyperoxiainducedbronchialhyperreactivitybysildenafilandvasoactiveintestinalpeptideimpactofpreservedlungfunctionandstructure AT donatiyves preventionofhyperoxiainducedbronchialhyperreactivitybysildenafilandvasoactiveintestinalpeptideimpactofpreservedlungfunctionandstructure AT belinxavier preventionofhyperoxiainducedbronchialhyperreactivitybysildenafilandvasoactiveintestinalpeptideimpactofpreservedlungfunctionandstructure AT pachejeanclaude preventionofhyperoxiainducedbronchialhyperreactivitybysildenafilandvasoactiveintestinalpeptideimpactofpreservedlungfunctionandstructure AT barazzoneargiroffoconstance preventionofhyperoxiainducedbronchialhyperreactivitybysildenafilandvasoactiveintestinalpeptideimpactofpreservedlungfunctionandstructure AT habrewalid preventionofhyperoxiainducedbronchialhyperreactivitybysildenafilandvasoactiveintestinalpeptideimpactofpreservedlungfunctionandstructure |